Scott Webster
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,701 of the $3,069 with a category attached, or 88.0%. It is spread thinly across 19 manufacturers, the largest accounting for just 17.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,107, 3.3 times the $334 reported in 2021.
Across 146 payments — averaging $21.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$536
- AbbVie$515
- Sun Pharmaceutical Industries Inc.$295
- LEO Pharma Inc.$288
- Pfizer$263
- Novartis$202
- plus $969 from 13 others
What the payments were for
- Food & beverage$2,70188%
- Education$36812%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 19 | $536 |
| AbbVie | 32 | $515 |
| Sun Pharmaceutical Industries Inc. | 10 | $295 |
| LEO Pharma Inc. | 14 | $288 |
| Pfizer | 17 | $263 |
| Novartis | 10 | $202 |
| Regeneron Healthcare Solutions, Inc. | 7 | $148 |
| Incyte Corporation | 3 | $119 |
| UCB, Inc. | 4 | $115 |
| VYNE Pharmaceuticals Inc. | 1 | $93 |
| Lilly USA, LLC | 5 | $91 |
| Amgen | 4 | $86 |
| Galderma Laboratories, L.p. | 5 | $84 |
| Dermavant Sciences, Inc. | 5 | $83 |
| Organon | 6 | $81 |
| Arcutis Biotherapeutics, Inc. | 1 | $21 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $16 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $14 |
How this compares
$3,069 in reported general payments places this provider in the 85th percentile of 1,460 family providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tacrolimus | 26 | $3,266 |
| Clobetasol Propionate | 76 | $2,130 |
| Fluorouracil | 29 | $1,769 |
| Ketoconazole | 75 | $1,117 |
| Fluocinonide | 16 | $557 |
| Triamcinolone Acetonide | 35 | $549 |
| Doxycycline Hyclate | 12 | $387 |
Paid to pharmacies, not to this prescriber.
Other family in Provo
- Kindra HuntProvo$118K
- Judd HunterProvo$32K
- Katelyn SianoProvo$29K
- Michael RobinsonProvo$16K
- Darin UsherProvo$15K
- Ashley RadmallProvo$8K
- Kylee MaliwaukiProvo$8K
- Riley WorthSandy$1.1M
- Katrina BawdenSalt Lake City$395K
- Cortnee RomanSalt Lake City$374K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.